Sign In

Alex Diamantopoulos

Founder and Director

Professional Background

Alex Diamantopoulos is a highly regarded business leader with over 15 years of extensive experience in health economics and outcomes research. As the founder of Symmetron, a global consulting firm, Alex has successfully positioned his company at the forefront of the pharmaceutical and biotech sectors. Specializing in payer strategy and market access, Symmetron is dedicated to collaborating closely with clients to craft impactful global value strategies. Through engagement with key opinion leaders, evidence generation, and the development of pricing strategies that accurately represent the value of pharmaceutical products, Symmetron has established itself as a formidable entity in the competitive marketplace.

Under Alex's leadership, Symmetron has achieved notable successes in evidence generation and synthesis, decision-analytic modelling, and statistical analysis in economic evaluations for both pharmaceuticals and medical devices. The firm's profound understanding of the health economics landscape, combined with its commitment to delivering tailored solutions, has made it a trusted partner for a wide range of clients seeking to understand and navigate the complexities of market access.

Education and Achievements

Alex Diamantopoulos boasts an impressive educational background that is foundational to his career in health economics. He earned his Bachelor of Science (BSc) in Economics from the esteemed Athens University of Economics and Business, where he developed a strong understanding of economic principles and analytical techniques. Following this, Alex pursued a Master of Science (MSc) in Health Economics and Health Policy at The University of Birmingham, further fortifying his expertise and equipping him with advanced skills and knowledge tailored to the healthcare sector.

Prior to establishing Symmetron, Alex gained invaluable experience serving as a Senior Economist at IMS Health, where he honed his abilities in economic evaluation and strategic insights, significantly impacting healthcare decision-making processes. Additionally, his role as an Economist at M-TAG provided him with a robust foundation in health economics, allowing him to contribute effectively to various projects and research initiatives.

Achievements

Throughout his career, Alex has not only led Symmetron to become a reputable consulting firm in the realm of healthcare but has also cultivated meaningful partnerships, aligning product value with payer expectations and market access strategies. His strategic insights and leadership have propelled Symmetron to numerous successful commercial activities.

By generating evidence-based strategies and conducting rigorous analyses, Alex has significantly contributed to the development of materials that help stakeholders make informed decisions regarding health technologies. His work not only enhances patient access to medications and therapies but also supports clients in aligning with prevailing health economic standards, ultimately benefiting the healthcare ecosystem as a whole.

Related Questions

How did Alex Diamantopoulos found Symmetron and why did he choose to focus on payer strategy and market access in the pharmaceutical industry?
What strategies has Alex Diamantopoulos implemented at Symmetron to engage key opinion leaders effectively in the health economics field?
In what ways has Alex Diamantopoulos's educational background in economics influenced his approach to health economics and outcomes research?
How has Alex Diamantopoulos's experience as a Senior Economist at IMS Health shaped his current methodologies in economic evaluations for pharmaceuticals?
What are the most significant challenges Alex Diamantopoulos has faced in the realm of health economics, and how has he overcome them in his professional journey?
A
Add to my network

Location

London, England, United Kingdom